🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To determine the dose limiting toxicity (DLT), the maxi...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT01907685
The purpose of this study is to determine the recommended dose of the combi...
Status
Completed
Location
Investigational Site Number 250001
Start Date
2008-07
Trial ID
NCT00719524
Treatments Being Tested
The primary objective of the study is to compare the progression-free survi...
Status
Completed
Location
Investigational Site Number 840004
Start Date
2008-06
Trial ID
NCT00699517
Treatments Being Tested
Primary Objectives: * To determine the excretion balance and systemic expo...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2010-01
Trial ID
NCT01063946
Treatments Being Tested
Primary Objective: \- To determine the maximum administered dose (MAD) and...
Status
Completed
Location
Investigational Site Number 250001
Start Date
2010-09
Trial ID
NCT01193595
Treatments Being Tested
Primary Objective: * To determine the maximum tolerated dose based on the ...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2010-03
Trial ID
NCT01021150
Treatments Being Tested
Primary Objective: \- To demonstrate an improvement in Progression-Free Su...
Status
Completed
Location
Investigational Site Number 840007
Start Date
2011-05
Trial ID
NCT01332656
Treatments Being Tested
Primary Objective: * To demonstrate progression free survival (PFS) improv...
Status
Completed
Location
Investigational Site Number 840001
Start Date
2011-02
Trial ID
NCT01263886
Treatments Being Tested
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Investigational Site Number 392002
Start Date
2011-01
Trial ID
NCT01293630
Treatments Being Tested
Primary objective: To determine the maximum tolerated dose based on the inc...
Status
Completed
Location
Sanofi-Aventis Investigational Site Number 392002
Start Date
2009-09
Trial ID
NCT00968916
Treatments Being Tested